02.22.16
INC Research, a global Phase I to IV contract research organization, has expanded its partnership with the Society for Clinical Research Sites (SCRS), becoming the first organization to be named a Circle of Innovation sponsor, a new level of commitment and the highest level of sponsorship aimed at increasing site support and site sustainability globally. Under the expanded partnership agreement, INC will be a lead supporter of SCRS' new Ambassador Program, which aims to extend SCRS membership and support to sites globally through regional activity around the world.
"INC Research has continued to grow our relationship with SCRS because our two organizations are well aligned in our shared commitment to site sustainability and providing sites across the globe a stronger voice in the clinical development process,” said Clare Grace, vice president, site and patient access, INC Research. "We are excited to be part of SCRS’ new Ambassador Program to expand vital support to even more sites around the world. Our initial focus will be on connecting with sites in the Asia/Pacific region. Through our participation, we can help facilitate better communication and work in a more collaborative way to address the unique needs and challenges these sites face, ultimately improving site support and sustainability.”
“The Ambassador Program offers a unique opportunity for organizations to participate in an unprecedented experience supporting site development and sustainability at a local and regional level,” said Christine Pierre, president, SCRS. "INC Research has been very supportive of our mission and purpose to further expand our efforts globally. We’re excited to advance our partnership to the next level through the launch of this program and see INC as playing a pivotal role as we work to support site development and sustainability on a more global scale."
As a Circle of Innovation sponsor, INC Research initially will sponsor the Ambassador Program in Australia, Japan, Korea, New Zealand, Taiwan and the United Kingdom and will provide scholarships for membership in SCRS to sites new to SCRS in these regions. In addition the company will expand its use of Site Advocacy Groups (SAGs) in 2016 to better incorporate the site voice in the conduct of clinical trials in fast-growing therapeutic areas representing significant patient need.
"INC Research has continued to grow our relationship with SCRS because our two organizations are well aligned in our shared commitment to site sustainability and providing sites across the globe a stronger voice in the clinical development process,” said Clare Grace, vice president, site and patient access, INC Research. "We are excited to be part of SCRS’ new Ambassador Program to expand vital support to even more sites around the world. Our initial focus will be on connecting with sites in the Asia/Pacific region. Through our participation, we can help facilitate better communication and work in a more collaborative way to address the unique needs and challenges these sites face, ultimately improving site support and sustainability.”
“The Ambassador Program offers a unique opportunity for organizations to participate in an unprecedented experience supporting site development and sustainability at a local and regional level,” said Christine Pierre, president, SCRS. "INC Research has been very supportive of our mission and purpose to further expand our efforts globally. We’re excited to advance our partnership to the next level through the launch of this program and see INC as playing a pivotal role as we work to support site development and sustainability on a more global scale."
As a Circle of Innovation sponsor, INC Research initially will sponsor the Ambassador Program in Australia, Japan, Korea, New Zealand, Taiwan and the United Kingdom and will provide scholarships for membership in SCRS to sites new to SCRS in these regions. In addition the company will expand its use of Site Advocacy Groups (SAGs) in 2016 to better incorporate the site voice in the conduct of clinical trials in fast-growing therapeutic areas representing significant patient need.